Brandon Hogstad, PhD is the founder of Morpheos LLC, an AI strategy and implementation consultancy for organizations where compliance, data sensitivity, and trust are non-negotiable. He helps firms in government contracting, legal, finance, health, and grant-funded sectors put AI to work safely: assessing workflows, developing governance and policy recommendations, then building and delivering the custom tools himself. Engagements ship in weeks, not quarters, and end with a trained team and a working system they own.
Brandon also serves as Security Lead for Morpheos. Because he designs, builds, and operates client systems himself, he is directly responsible for their security: access control and authentication, data handling, secure-development practices, and vulnerability review and remediation for Morpheos-operated tools and client implementations.
Brandon is a frequent speaker on AI adoption and strategy, delivering executive briefings, hands-on training retreats, and workshops for leadership teams navigating a fast-moving landscape.
Before founding Morpheos, he built drug-discovery accelerator programs at NYU Langone Health, forging collaborations with Sanofi and Pfizer and contributing research that informed Paxlovid. He later led AI-driven immunotherapy initiatives at Immunai, applying machine learning and single-cell genomics to precision medicine.
Brandon earned his PhD in Biomedical Sciences from the Icahn School of Medicine at Mount Sinai; his work has appeared in Nature and the Journal of Experimental Medicine. Outside of work, he co-hosts the dream-interpretation podcast Let's Talk About Dreams and releases music with his brother as The Hogstad Brothers.